Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Prometheus Biosciences, Inc. (RXDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Hendrix Martin (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 2,071 shares
@ $0
Disposed/sold 40,000 options to buy
@ $22.48, valued at
$899.2k
Disposed/sold 20,500 options to buy
@ $29.02, valued at
$594.9k
|
|
| 06/16/2023 |
4
| Laur James (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 2,071 shares
@ $0
Disposed/sold 40,000 options to buy
@ $22.48, valued at
$899.2k
Disposed/sold 20,500 options to buy
@ $29.02, valued at
$594.9k
|
|
| 06/16/2023 |
4
| Stenhouse Mark (COO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 12,754 shares
@ $0
Disposed/sold 14,000 shares
@ $0
Disposed/sold 40,000 options to buy
@ $0.5, valued at
$20k
Disposed/sold 240,000 options to buy
@ $6.7, valued at
$1.6M
Disposed/sold 70,371 options to buy
@ $36.32, valued at
$2.6M
Disposed/sold 86,582 options to buy
@ $29.56, valued at
$2.6M
Disposed/sold 34,085 options to buy
@ $110.2, valued at
$3.8M
|
|
| 06/16/2023 |
4
| Szela Mary T (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 2,071 shares
@ $0
Disposed/sold 40,000 options to buy
@ $19, valued at
$760k
Disposed/sold 20,500 options to buy
@ $29.02, valued at
$594.9k
|
|
| 06/16/2023 |
4
| McKenna Mark C. (Chairman, President and CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 178,098 shares
@ $0
Disposed/sold 161,105 options to buy
@ $2.9, valued at
$467.2k
Disposed/sold 132,741 options to buy
@ $1.7, valued at
$225.7k
Disposed/sold 20,000 options to buy
@ $3.1, valued at
$62k
Disposed/sold 481,725 options to buy
@ $3.7, valued at
$1.8M
Disposed/sold 566,307 options to buy
@ $6.7, valued at
$3.8M
Disposed/sold 290,000 options to buy
@ $36.32, valued at
$10.5M
Disposed/sold 246,639 options to buy
@ $29.56, valued at
$7.3M
Disposed/sold 128,930 options to buy
@ $110.2, valued at
$14.2M
|
|
| 06/16/2023 |
4
| Swain Judith L (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 2,071 shares
@ $0
Disposed/sold 30,000 options to buy
@ $6.7, valued at
$201k
Disposed/sold 20,500 options to buy
@ $29.02, valued at
$594.9k
|
|
| 06/16/2023 |
4
| PAPA JOSEPH C (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 7,278 shares
@ $0
Disposed/sold 10,000 shares
@ $0
Disposed/sold 15,000 options to buy
@ $3.1, valued at
$46.5k
Disposed/sold 27,340 options to buy
@ $3.7, valued at
$101.2k
Disposed/sold 22,652 options to buy
@ $6.7, valued at
$151.8k
Disposed/sold 2,165 options to buy
@ $36.32, valued at
$78.6k
Disposed/sold 22,551 options to buy
@ $29.02, valued at
$654.4k
|
|
| 06/16/2023 |
4
| Hassan Fred (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 2,123 shares
@ $0
Disposed/sold 40,000 options to buy
@ $16.82, valued at
$672.8k
Disposed/sold 541 options to buy
@ $36.32, valued at
$19.6k
Disposed/sold 21,013 options to buy
@ $29.02, valued at
$609.8k
|
|
| 06/16/2023 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 87,973 shares
@ $0
Disposed/sold 52,838 options to buy
@ $3.1, valued at
$163.8k
Disposed/sold 93,040 options to buy
@ $3.7, valued at
$344.2k
Disposed/sold 135,913 options to buy
@ $6.7, valued at
$910.6k
Disposed/sold 102,155 options to buy
@ $36.32, valued at
$3.7M
Disposed/sold 86,582 options to buy
@ $29.56, valued at
$2.6M
Disposed/sold 34,085 options to buy
@ $110.2, valued at
$3.8M
Disposed/sold 12,920 options to buy
@ $108.76, valued at
$1.4M
|
|
| 06/16/2023 |
4
| Adams Helen C. (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 2,674 shares
@ $0
Disposed/sold 30,000 options to buy
@ $6.7, valued at
$201k
Disposed/sold 1,083 options to buy
@ $36.32, valued at
$39.3k
Disposed/sold 21,526 options to buy
@ $29.02, valued at
$624.7k
|
|
| 06/02/2023 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Exercised 122,528 options to buy
@ $2.9, valued at
$355.3k
Exercised 3 options to buy
@ $1.7, valued at
$5.1 |
|
| 06/02/2023 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Exercised 78,162 options to buy
@ $3.1, valued at
$242.3k
|
|
| 06/02/2023 |
4
| Stenhouse Mark (COO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed of 14,000 shares
@ $0
Acquired 14,000 shares
@ $0 |
|
| 06/02/2023 |
4
| PAPA JOSEPH C (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed of 10,000 shares
@ $0
Acquired 10,000 shares
@ $0 |
|
| 05/19/2023 |
4
| Szela Mary T (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 2,071 shares
@ $0 |
|
| 05/19/2023 |
4
| Swain Judith L (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 2,071 shares
@ $0 |
|
| 05/19/2023 |
4
| PAPA JOSEPH C (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 2,278 shares
@ $0 |
|
| 05/19/2023 |
4
| Laur James (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 2,071 shares
@ $0 |
|
| 05/19/2023 |
4
| Hendrix Martin (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 2,071 shares
@ $0 |
|
| 05/19/2023 |
4
| Hassan Fred (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 2,123 shares
@ $0 |
|
| 05/19/2023 |
4
| Adams Helen C. (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 2,174 shares
@ $0 |
|
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2023 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Sold 10,000 shares
@ $122.13, valued at
$1.2M
Exercised 10,000 options to buy
@ $3.7, valued at
$37k
|
|
| 03/08/2023 |
4
| Cedars Sinai Intellectual Property Co (10% Owner) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Sold 865,000 shares
@ $114.59, valued at
$99.1M
|
|
| 03/03/2023 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Sold 700 shares
@ $125.26, valued at
$87.7k
Sold 10,620 shares
@ $125.13, valued at
$1.3M
Exercised 700 options to buy
@ $3.7, valued at
$2.6k
Exercised 10,620 options to buy
@ $3.7, valued at
$39.3k
|
|
| 01/19/2023 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Sold 5,000 shares
@ $119, valued at
$595k
Exercised 5,000 options to buy
@ $3.7, valued at
$18.5k
|
|
| 01/19/2023 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Sold 25,000 shares
@ $118.99, valued at
$3M
Exercised 25,000 options to buy
@ $2.9, valued at
$72.5k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|